title: An evaluation of Droperidol for preventing nausea and vomiting after deep intravenous sedation for ambulatory dental surgery.
abstract: Four sets of 25 patients were given either 0, 0.25, 0.50, or 1.00 mg droperidol intravenously during deep intravenous sedation for dental surgery in a nonrandomly assigned, single-blind, prospective clinical trial. The control group experienced a 48% incidence of nausea or vomiting, while each of the experimental groups experienced a significantly lower incidence of nausea or vomiting (P = 0.0026). All nausea or vomiting occurred after the patients were discharged and appeared to be motion-related.
authors.forename: L D
authors.initials: LD
authors.lastname: Trapp
mesh_terms: D000553:Ambulatory Care; D000766:Anesthesia, Dental / Q000009:adverse effects; D000771:Anesthesia, Intravenous / Q000009:adverse effects; D004329:Droperidol / Q000627:therapeutic use*; D006801:Humans; D009325:Nausea / Q000517:prevention & control*; D014839:Vomiting / Q000517:prevention & control*
chemical_list: D004329:Droperidol